A worldwide leader in technology transfer

2

2

Safe Harbor

Certain matters discussed in this presentation are "forward-looking statements". These forward-looking statements can generally be identified as such because the context of the statement will include words such as the Company "expects," "anticipates" or words of similar import. Similarly, statements that describe the Company's future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of the Company and market valuations of its stock, which could cause actual results to differ materially from those currently anticipated. Although the Company believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, the Company can give no assurance that its expectations will be attained. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating any forward-looking statements. Forward-looking statements made herein are only made as of the date of this presentation and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

© 2005 UTEK CORPORATION

3

3

Corporate Overview

First market-driven technology transfer company Enable public companies to rapidly acquire innovative

technologies from universities and research laboratories

Only company that facilitates the identification and acquisition of external technologies by clients in exchange for their equity

Research institutions receive 100% of the royalties

4

4

Industry Background

Supply Top U.S., U.K. & Canadian research institutions spend more than

$40 billion on research annually – Develop more than 17,700 new technologies annually– Approximately 70% of these new technologies go unlicensed

Demand Small to mid-sized public companies have a significant need for

new technology infusions:– Limited resources to conduct & finance research– Limited awareness of and access to university & laboratory

research

(2003 Association of University Technology Managers Licensing Survey & UK University Commercialisation Survey: Financial Year 2002 Nottingham University Business School)

7

7

UTEK: The New Paradigm

UTEK:

•Locates, evaluates, acquires and transfers intellectual property

•No Inventory

•No Incubation

•Delivering university technologies to public companies

“Just in time technology transfer”

8

8

Case Study

Circle Group Holdings, Inc. (AMEX:CXN)

•Fiber-Gel is a patented, fat replacement developed by the USDA•CXN equity appreciated from the original date of transfer over 400%

Note: Results may vary significantly, based on the technology transferred and a wide variety of client-specific factors

11

11

U2B® Business Model

© 2005 UTEK CORPORATION

12

12

U2B® Fulfillment Process: Search Phase

Goal– Source breakthrough new technology for client. Present to client, on

average, three powerful Technology Acquisition Opportunities each month

– Client pays retainer during search phase Search Process

– Develop Technology Search Profile – Send technology profile to UTEK’s technology suppliers– Perform in-house search utilizing UTEK proprietary online IP exchanges– Filter R&D candidates to ensure fit and scientific merit– Validate the science with the Scientific Advisory Council – Present Acquisition Opportunities

13

13

    

U2B® Fulfillment Process: Transfer Phase

Client is interested in a specific technology presented by UTEK:

Deliver confidential information for review Assist in due diligence Conduct conference calls and on-site laboratory visits

  Arms length negotiation and acquisition process, UTEK: Negotiates terms with technology licensor Negotiates transfer terms with clients  Creates IP acquisition company and acquires technology license

rights and consulting agreements with primary investigator Client acquires UTEK IP acquisition company for stock

14

14

Market Driven Technology Transfer

Customer focused Biomedical Pharmaceutical Telecommunications Software Safety and security Environmental Nutraceuticals

Life sciences

Physical sciences

Sector Breakdown

Unweighted, by number of customer investee companies as at 31 Dec 2004

15

15

Science Advisory Council

Assembled Scientific Advisory Council to assist in science review of technology acquisitions.

35 members, including one Nobel laureate, two university presidents and two department chairs:

– Walter Kohn, Ph.D., - Physical chemistry, University of California at Santa Barbara (Nobel Prize recipient)

– Marcel Crochet, Ph.D. - Fluid mechanics, Rector of the Catholic University of Louvain, Belgium

– Anders Flodström, Ph.D. - Semiconductor physics, President of the Royal Institute of Technology, Sweden

– Ralph S. Greco, M.D. - General, endocrine and gastrointestinal surgery, Division Head of General Surgery, Stanford University School of Medicine

– Andrew P. McMahon, Ph.D. - Developmental genetics, Chairman, Department of Molecular and Cellular Biology, Harvard University

16

16

Current and Past Clients (Partial Listing)

17

17

UTEK Technology Transfer Companies

IP TECHNOLOGY TRANSFER

IP TECHNOLOGY TRANSFER

PROPRIETARY IP DATABASES

PROPRIETARY IP DATABASES

Software and servicesto manage and analyze

intellectual property

Services to identify intellectual property

IP MANAGEMENTIP MANAGEMENT

Services to acquire and transfer intellectual property

19

19

Summary

A worldwide leader in technology transfer Successfully completed 47 transfers to date

– 9 transfers from federal laboratories Highly regarded Scientific Advisory Council Global network of >250 university and laboratory

technology suppliers UTEK is willing to invest its capital in each transfer